Helmut Hohne

Title: Helmut Hohne: Innovator in Antibiotic Development

Introduction

Helmut Hohne is a notable inventor based in Bad Soden, Germany. He has made significant contributions to the field of antibiotic development, particularly through his work with the strain Streptomyces tendae Ettlinger. With a total of 2 patents, Hohne's innovations have the potential to impact medical treatments significantly.

Latest Patents

Hohne's latest patents focus on a fungicidally active antibiotic derived from Streptomyces tendae Ettlinger. The new antibiotic, Nikkomycin, is produced by culturing the strain in a nutrient medium at a pH of about 5.5 to 8 under aerobic conditions. The isolation process involves cation exchange from the culture filtrate, followed by elution. This antibiotic is characterized by its structural formula and is noted for its fungicidal activity.

Career Highlights

Helmut Hohne is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on innovative solutions in antibiotic research, contributing to advancements in medical science.

Collaborations

Hohne has collaborated with esteemed colleagues such as Hanspaul Hagenmaier and Wilfried Konig. These partnerships have fostered a collaborative environment that enhances the research and development of new antibiotics.

Conclusion

Helmut Hohne's contributions to antibiotic development exemplify the importance of innovation in healthcare. His work continues to pave the way for new treatments that can combat fungal infections effectively.